ACCESS HOPE CRO

The promise of Right to Try for patients is to create access to experimental drugs. The promise of Right to Try for the treatment community is to provide physicians with possible treatment options and hope for their most needy patients. The promise of Right to Try for the biopharma industry is the ability to tap into a new source of Real World Data to create pre-approval insights that will help shape and guide the ever increasing burdens of drug development. Our vision at Access Hope CRO is to enable the promise of Right to Try for all three communities... Access Hope CRO is the first CRO founded exclusively to facilitate Right to Try Treatment programs at scale for the biopharmaceutical industry. We can design, recruit, and manage sites and patients for Right to Try compliant expanded access treatment programs under the new Right to Try legislation; as well as collect observational and Real World data with our extremely cost efficient custom eCRF system.